Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Merlo-Pich

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|September 13, 1996
Appetite-suppressing effects of urocortin, a CRF-related neuropeptideM Spina, E Merlo-Pich, R K Chan, et al.
Gene Therapy|February 4, 1999
Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factorP Ghersa, R P Gobert, P Sattonnet-Roche, et al.
Neuroreport|November 26, 1999
Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusionN le Novère, M Zoli, C Léna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1995
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysisE Merlo Pich, M Lorang, M Yeganeh, et al.
Stroke|February 1, 1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in ratsE Merlo Pich, R Grimaldi, M Zoli, et al.
Journal of Hypertension|November 1, 1994
Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise testF Fontana, P Bernardi, E Merlo Pich, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in ratsF Rodríguez de Fonseca, P Rubio, F Menzaghi, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1984
Studies on aging processesL F Agnati, K Fuxe, F Benfenati, et al.
Neurochemistry International|May 28, 2010
Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidolL F Agnati, K Fuxe, M Ruggeri, et al.
Nature Neuroscience|March 29, 2001
Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient miceA M Salmon, M I Damaj, L M Marubio, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|September 13, 1996
Appetite-suppressing effects of urocortin, a CRF-related neuropeptideM Spina, E Merlo-Pich, R K Chan, et al.
Gene Therapy|February 4, 1999
Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factorP Ghersa, R P Gobert, P Sattonnet-Roche, et al.
Neuroreport|November 26, 1999
Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusionN le Novère, M Zoli, C Léna, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1995
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysisE Merlo Pich, M Lorang, M Yeganeh, et al.
Stroke|February 1, 1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in ratsE Merlo Pich, R Grimaldi, M Zoli, et al.
Journal of Hypertension|November 1, 1994
Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise testF Fontana, P Bernardi, E Merlo Pich, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in ratsF Rodríguez de Fonseca, P Rubio, F Menzaghi, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1984
Studies on aging processesL F Agnati, K Fuxe, F Benfenati, et al.
Neurochemistry International|May 28, 2010
Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidolL F Agnati, K Fuxe, M Ruggeri, et al.
Nature Neuroscience|March 29, 2001
Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient miceA M Salmon, M I Damaj, L M Marubio, et al.
Pageof 5